Divergence Neuro
PrivateLast Round
Seed
Nov 18, 2022
Total Funding Raised
$86,000
Company Overview
Divergence Neuro operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Grant round in March 2022.
Divergence Neuro is a health technology company that provides a cloud-based, remote neurofeedback and biofeedback platform for therapists, coaches, and researchers to improve patient mental health outcomes.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Vertical SaaS, Telemedicine, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Divergence Neuro Comparables
Compare Divergence Neuro with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Myndlift | 88% | |
| BEE Medic | 77% | |
| NewMind Technologies | 77% |
For institutional investors. Book with your work email.
Divergence Neuro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 18, 2022 | ||||
| Grant | Mar 1, 2022 | ||||
| Angel | Jun 1, 2021 | ||||
| Grant | Jan 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Divergence Neuro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Mitacs | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2026
Monthly visitors increased 125% MoM, reaching 7,000.
- Nov 6, 2025
Monthly visitors grew 77% MoM, reaching 8.4K.
For institutional investors. Book with your work email.
Divergence Neuro Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Divergence Neuro's valuation, stock price, and market status.
Is Divergence Neuro a public or private company?
Divergence Neuro is a private company.
What is the current stock price of Divergence Neuro?
Divergence Neuro is a private company, so its shares have no public market price. Caplight tracks Divergence Neuro's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Divergence Neuro worth (valuation)?
Valuation information for Divergence Neuro is not publicly available.
Can I buy Divergence Neuro stock?
Divergence Neuro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Divergence Neuro's last funding round?
Divergence Neuro's most recent funding round was Seed on November 18, 2022.
Who are the main investors in Divergence Neuro?
Key investors in Divergence Neuro include National Research Council Canada Industrial Research Assistance Program, Mitacs.
Will Divergence Neuro IPO soon?
No public IPO plans have been announced for Divergence Neuro.
How can I track Divergence Neuro secondary market activity?
Caplight tracks bids, offers, and trades in Divergence Neuro's shares on secondary markets.